Article
Clinical azole cross-resistance in Candida parapsilosis is related to a novel MRR1 gain-of-function mutation.
Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases - 1 Dec 2022
Branco Joana, Ryan Adam P, Pinto E Silva Ana, Butler Geraldine, Miranda Isabel M, Rodrigues Acácio G
Abstract excerpt
OBJECTIVES: Hereby, we describe the molecular mechanisms underlying the acquisition of azole resistance by a Candida parapsilosis isolate following fluconazole treatment due to candiduria. METHODS: A set of three consecutive C. parapsilosis isolates were recovered from the urine samples of a patient with candiduria. Whole-genome sequencing and antifungal susceptibility assays were performed. The expression of...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
